scholarly journals The incidence and clinical features of meconium aspiration syndrome: a two-year neonatal intensive care experience

Author(s):  
Atiye Fedakar
PEDIATRICS ◽  
1991 ◽  
Vol 87 (2) ◽  
pp. 269-269
Author(s):  
THOMAS E. WISWELL

In Reply.— I appreciate the comments of Dr Traverse. His opinions and practices closely reflect my own. I, too, am unaware of proven long-term sequelae which can be attributed directly to intubating meconium-stained infants once or twice.1 Additionally, I attempt to remove meconium from the upper airway in all meconium-stained infants, be they vigorous or healthy, or the meconium thick or thin. During the past 5 years, fully one third of infants with the meconium aspiration syndrome (MAS) admitted to our Neonatal Intensive Care Unit had not been intubated and had their tracheae suctioned.


2021 ◽  
Vol 11 (8) ◽  
pp. 695
Author(s):  
Jen-Fu Hsu ◽  
Ying-Feng Chang ◽  
Hui-Jun Cheng ◽  
Chi Yang ◽  
Chun-Yuan Lin ◽  
...  

Background: preterm and critically ill neonates often experience clinically suspected sepsis during their prolonged hospitalization in the neonatal intensive care unit (NICU), which can be the initial sign of final adverse outcomes. Therefore, we aimed to utilize machine learning approaches to predict neonatal in-hospital mortality through data-driven learning. Methods: a total of 1095 neonates who experienced clinically suspected sepsis in a tertiary-level NICU in Taiwan between August 2017 and July 2020 were enrolled. Clinically suspected sepsis was defined based on clinical features and laboratory criteria and the administration of empiric antibiotics by clinicians. The variables used for analysis included patient demographics, clinical features, laboratory data, and medications. The machine learning methods used included deep neural network (DNN), k-nearest neighbors, support vector machine, random forest, and extreme gradient boost. The performance of these models was evaluated using the area under the receiver operating characteristic curve (AUC). Results: the final in-hospital mortality of this cohort was 8.2% (90 neonates died). A total of 765 (69.8%) and 330 (30.2%) patients were randomly assigned to the training and test sets, respectively. Regarding the efficacy of the single model that most accurately predicted the outcome, DNN exhibited the greatest AUC (0.923, 95% confidence interval [CI] 0.953–0.893) and the best accuracy (95.64%, 95% CI 96.76–94.52%), Cohen’s kappa coefficient value (0.74, 95% CI 0.79–0.69) and Matthews correlation coefficient value (0.75, 95% CI 0.80–0.70). The top three most influential variables in the DNN importance matrix plot were the requirement of ventilator support at the onset of suspected sepsis, the feeding conditions, and intravascular volume expansion. The model performance was indistinguishable between the training and test sets. Conclusions: the DNN model was successfully established to predict in-hospital mortality in neonates with clinically suspected sepsis, and the machine learning algorithm is applicable for clinicians to gain insights and have better communication with families in advance.


2013 ◽  
Vol 30 (3) ◽  
pp. 259-264 ◽  
Author(s):  
Holly Roberts ◽  
Howard Needelman ◽  
Barbara Jackson ◽  
Carol McMorris ◽  
Abbey Munyon

Author(s):  
Jin Youp Kim ◽  
Doh Young Lee ◽  
Hyun Chang ◽  
Dong Wook Kim ◽  
Myung-Whun Sung ◽  
...  

2018 ◽  
Vol 36 (03) ◽  
pp. 262-267 ◽  
Author(s):  
Elizabeth Thompson ◽  
Krystle Perez ◽  
P. Smith ◽  
Reese Clark ◽  
Matthew Laughon ◽  
...  

Objective Pulmonary hypertension causes substantial morbidity and mortality in infants. Although Food and Drug Administration approved to treat pulmonary arterial hypertension in adults, sildenafil is not approved for infants. We sought to describe sildenafil exposure and associated diagnoses and outcomes in infants. Study Design Retrospective cohort of neonates discharged from more than 300 neonatal intensive care units from 2001 to 2016. Results Sildenafil was administered to 1,336/1,161,808 infants (0.11%; 1.1 per 1,000 infants); 0/35,977 received sildenafil in 2001 versus 151/90,544 (0.17%; 1.7 per 1,000 infants) in 2016. Among infants <32 weeks' gestational age (GA) with enough data to determine respiratory outcome, 666/704 (95%) had bronchopulmonary dysplasia (BPD). Among infants ≥32 weeks GA, 248/455 (55%) had BPD and 76/552 (14%) were diagnosed with meconium aspiration. Overall, 209/921 (23%) died prior to discharge. Conclusion The use of sildenafil has increased since 2001. Exposed infants were commonly diagnosed with BPD. Further studies evaluating dosing, safety, and efficacy of sildenafil are needed.


1991 ◽  
Vol 20 (1) ◽  
pp. 15-18 ◽  
Author(s):  
Jeanne Donelan Rapack

Sign in / Sign up

Export Citation Format

Share Document